This past week Nate and I had the opportunity to spend some more time at the capital and meet with legislators to discuss current issues in pharmacy! Everyone who we have spoken with has been very receptive and supportive of our proposed audit standardization bill. I am hoping the bill is dropped soon, so that Nate and I can see how this process works firsthand! I was able to some research on US Senate Bill 296: Preserving Access to Life-Saving Medications Act proposed by Senators Amy Klouchar (D-Minn) and Bob Casey (D-Pa) for this months E-News. This bill mandates manufacturers to notify the FDA in instances where they believe their is the potential for manufacturing delay leading to a potential drug shortage. There are many more details to the bill but the basic idea behind the bill is better communication with the FDA to avoid drug shortages!
On Friday we were able to go on a field trip to Blomberg Pharmacy, a local independent pharmacy in St. Paul MN. It was great to see independent pharmacy in action-- the patients knew the employees by name, weren't afraid to ask questions and the pharmacist had time to provide individual attention to each patient. This week we also completed many administrative tasks including sorting out CE certification, soliciting members for the Board of Directors, finalizing articles for the E-News and covering MPhA budget/finance basics. I am continuing to work on providing a list of updates needed to the MPhA website—I would appreciate any and all feedback about the MPhA website, as we start to update it. Is there anything you would like to see that is not on there? Things that need to be removed? I am here to help!
Please feel free to contact me or anyone at MPhA if you have questions about accessing your CE certification, if you are interested in becoming a Board Member for MPhA or if you have any feedback about the E-News! We love to hear from you!
--
Gina E. Rozinka
PharmD Candidate Class of 2011
University of Minnesota
College of Pharmacy
Rozi0007@umn.edu
612-385-8167
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment